Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFKS8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,919
Award facts
- Contract value 100% obligated
- $1,919.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 100-unit vials of BOTOX on January 6, 2026. This firm fixed-price delivery order, valued at $1,919.48 with an ultimate completion date of January 28, 2026, was issued without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was established on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036.
DMS Pharmaceutical Group has been a registered federal contractor since 2001 and serves as a critical pharmaceutical supplier for Department of Defense healthcare operations globally. The PPV-G GEN V program, part of the broader $30.3 billion acquisition strategy, enables DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables to support military healthcare facilities worldwide. This BOTOX delivery order exemplifies the company's established performance in supplying specialized pharmaceutical products across multiple therapeutic categories to support recurring medical supply needs of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FFKS8?
SPE2DR26FFKS8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FFKS8 worth?
The government has obligated $1,919 on SPE2DR26FFKS8.
Is contract SPE2DR26FFKS8 an order under another contract?
Yes. SPE2DR26FFKS8 is a delivery order under SPE2DR25D9212, an indefinite delivery contract.
Was contract SPE2DR26FFKS8 competed?
The extent of competition for SPE2DR26FFKS8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award